STOCK TITAN

[Form 3/A] iRhythm Technologies, Inc Amended Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3/A

Form 3/A overview: iRhythm Technologies, Inc. (IRTC) filed an amended Form 3 for newly appointed Chief Technology Officer Brian Lee Lawrence. The amendment, dated 06/27/2025, corrects the original 04/21/2025 filing by attaching the Power of Attorney that was previously omitted.

Key points for investors:

  • No securities owned: The report states that Mr. Lawrence currently holds zero shares or derivative securities of IRTC.
  • Administrative nature: No changes to capital structure, operations, or financial outlook are disclosed; the sole purpose is to provide the missing document.
  • Insider alignment: The absence of ownership may indicate limited immediate equity alignment between the CTO and shareholders, although incentive grants can follow after employment begins.

This filing is largely procedural and does not contain material financial information or signal any strategic shift for iRhythm.

Panoramica del Modulo 3/A: iRhythm Technologies, Inc. (IRTC) ha presentato un Modulo 3 modificato per il nuovo Chief Technology Officer Brian Lee Lawrence. La modifica, datata 27/06/2025, corregge la presentazione originale del 21/04/2025 allegando il Potere di Procuratore precedentemente omesso.

Punti chiave per gli investitori:

  • Nessuna partecipazione azionaria: Il rapporto indica che il Sig. Lawrence attualmente non possiede azioni o strumenti derivati di IRTC.
  • Natura amministrativa: Non sono riportate modifiche alla struttura del capitale, alle operazioni o alle prospettive finanziarie; lo scopo è esclusivamente fornire il documento mancante.
  • Allineamento degli insider: L’assenza di proprietà può indicare un limitato allineamento azionario immediato tra il CTO e gli azionisti, sebbene possano essere concessi incentivi dopo l’inizio dell’impiego.

Questa comunicazione ha carattere principalmente procedurale e non contiene informazioni finanziarie rilevanti né indica cambiamenti strategici per iRhythm.

Resumen del Formulario 3/A: iRhythm Technologies, Inc. (IRTC) presentó un Formulario 3 enmendado para el nuevo Director de Tecnología, Brian Lee Lawrence. La enmienda, fechada el 27/06/2025, corrige la presentación original del 21/04/2025 incluyendo el Poder Notarial que había sido omitido previamente.

Puntos clave para inversores:

  • No posee valores: El informe indica que el Sr. Lawrence actualmente no posee acciones ni valores derivados de IRTC.
  • Carácter administrativo: No se revelan cambios en la estructura de capital, operaciones o perspectivas financieras; el único propósito es proporcionar el documento faltante.
  • Alineación interna: La ausencia de propiedad puede reflejar una limitada alineación inmediata de capital entre el CTO y los accionistas, aunque pueden otorgarse incentivos tras el inicio del empleo.

Esta presentación es principalmente de carácter procedural y no contiene información financiera material ni indica un cambio estratégico para iRhythm.

서식 3/A 개요: iRhythm Technologies, Inc. (IRTC)는 새로 임명된 최고기술책임자(CTO) Brian Lee Lawrence에 대해 수정된 서식 3을 제출했습니다. 2025년 6월 27일자 이 수정 서류는 2025년 4월 21일 원본 제출에서 누락된 위임장을 첨부하여 바로잡은 것입니다.

투자자를 위한 주요 사항:

  • 보유 주식 없음: 보고서에 따르면 Lawrence 씨는 현재 IRTC의 주식이나 파생 증권을 전혀 보유하지 않고 있습니다.
  • 행정적 성격: 자본 구조, 운영, 재무 전망에 대한 변경 사항은 없으며, 누락된 서류를 제출하는 것이 유일한 목적입니다.
  • 내부자 정렬: 보유 주식이 없다는 점은 CTO와 주주 간의 즉각적인 지분 정렬이 제한적임을 시사할 수 있으나, 고용 시작 후 인센티브 부여가 있을 수 있습니다.

이번 제출은 주로 절차적인 성격이며, 중요한 재무 정보나 iRhythm의 전략적 변화 신호를 포함하지 않습니다.

Présentation du formulaire 3/A : iRhythm Technologies, Inc. (IRTC) a déposé un formulaire 3 modifié pour le nouveau Directeur Technique (CTO) Brian Lee Lawrence. L’amendement, daté du 27/06/2025, corrige la déclaration initiale du 21/04/2025 en joignant la procuration qui avait été omise précédemment.

Points clés pour les investisseurs :

  • Aucune valeur détenue : Le rapport indique que M. Lawrence ne détient actuellement aucune action ni valeur dérivée d’IRTC.
  • Nature administrative : Aucun changement dans la structure du capital, les opérations ou les perspectives financières n’est divulgué ; le seul but est de fournir le document manquant.
  • Alignement des initiés : L’absence de détention peut indiquer un alignement en actions limité à court terme entre le CTO et les actionnaires, bien que des attributions d’incitations puissent suivre après le début de l’emploi.

Ce dépôt est essentiellement de nature procédurale et ne contient aucune information financière importante ni ne signale un changement stratégique pour iRhythm.

Überblick über Formular 3/A: iRhythm Technologies, Inc. (IRTC) reichte ein geändertes Formular 3 für den neu ernannten Chief Technology Officer Brian Lee Lawrence ein. Die Änderung vom 27.06.2025 korrigiert die ursprüngliche Einreichung vom 21.04.2025, indem die zuvor fehlende Vollmacht beigefügt wurde.

Wichtige Punkte für Investoren:

  • Keine Wertpapiere im Besitz: Der Bericht gibt an, dass Herr Lawrence derzeit keine Aktien oder derivative Wertpapiere von IRTC hält.
  • Administrativer Charakter: Es werden keine Änderungen an der Kapitalstruktur, den Geschäftsabläufen oder der finanziellen Prognose offengelegt; der einzige Zweck ist die Bereitstellung des fehlenden Dokuments.
  • Insider-Ausrichtung: Das Fehlen von Eigentum könnte auf eine begrenzte unmittelbare Eigenkapitalausrichtung zwischen dem CTO und den Aktionären hinweisen, obwohl Anreizzuteilungen nach Beginn der Anstellung erfolgen können.

Diese Einreichung ist überwiegend prozedural und enthält keine wesentlichen finanziellen Informationen oder signalisiert eine strategische Veränderung bei iRhythm.

Positive
  • None.
Negative
  • CTO reports zero share ownership, suggesting limited immediate equity alignment between new executive and shareholders until future grants are disclosed.

Insights

TL;DR – Routine amendment; no stock owned, minimal investor impact.

The 3/A simply appends a missing Power of Attorney to Mr. Lawrence’s initial Form 3. Because the filing confirms he owns no common or derivative securities, there is no dilution, insider buying, or selling to evaluate. From a governance perspective, attaching the PoA fulfills SEC Rule 16a compliance and removes potential filing deficiencies. Investors should view this as clerical; it neither enhances nor detracts from the company’s outlook. Lack of insider ownership may raise questions about executive incentive alignment, but such grants often occur after onboarding and would appear in future Forms 4.

Panoramica del Modulo 3/A: iRhythm Technologies, Inc. (IRTC) ha presentato un Modulo 3 modificato per il nuovo Chief Technology Officer Brian Lee Lawrence. La modifica, datata 27/06/2025, corregge la presentazione originale del 21/04/2025 allegando il Potere di Procuratore precedentemente omesso.

Punti chiave per gli investitori:

  • Nessuna partecipazione azionaria: Il rapporto indica che il Sig. Lawrence attualmente non possiede azioni o strumenti derivati di IRTC.
  • Natura amministrativa: Non sono riportate modifiche alla struttura del capitale, alle operazioni o alle prospettive finanziarie; lo scopo è esclusivamente fornire il documento mancante.
  • Allineamento degli insider: L’assenza di proprietà può indicare un limitato allineamento azionario immediato tra il CTO e gli azionisti, sebbene possano essere concessi incentivi dopo l’inizio dell’impiego.

Questa comunicazione ha carattere principalmente procedurale e non contiene informazioni finanziarie rilevanti né indica cambiamenti strategici per iRhythm.

Resumen del Formulario 3/A: iRhythm Technologies, Inc. (IRTC) presentó un Formulario 3 enmendado para el nuevo Director de Tecnología, Brian Lee Lawrence. La enmienda, fechada el 27/06/2025, corrige la presentación original del 21/04/2025 incluyendo el Poder Notarial que había sido omitido previamente.

Puntos clave para inversores:

  • No posee valores: El informe indica que el Sr. Lawrence actualmente no posee acciones ni valores derivados de IRTC.
  • Carácter administrativo: No se revelan cambios en la estructura de capital, operaciones o perspectivas financieras; el único propósito es proporcionar el documento faltante.
  • Alineación interna: La ausencia de propiedad puede reflejar una limitada alineación inmediata de capital entre el CTO y los accionistas, aunque pueden otorgarse incentivos tras el inicio del empleo.

Esta presentación es principalmente de carácter procedural y no contiene información financiera material ni indica un cambio estratégico para iRhythm.

서식 3/A 개요: iRhythm Technologies, Inc. (IRTC)는 새로 임명된 최고기술책임자(CTO) Brian Lee Lawrence에 대해 수정된 서식 3을 제출했습니다. 2025년 6월 27일자 이 수정 서류는 2025년 4월 21일 원본 제출에서 누락된 위임장을 첨부하여 바로잡은 것입니다.

투자자를 위한 주요 사항:

  • 보유 주식 없음: 보고서에 따르면 Lawrence 씨는 현재 IRTC의 주식이나 파생 증권을 전혀 보유하지 않고 있습니다.
  • 행정적 성격: 자본 구조, 운영, 재무 전망에 대한 변경 사항은 없으며, 누락된 서류를 제출하는 것이 유일한 목적입니다.
  • 내부자 정렬: 보유 주식이 없다는 점은 CTO와 주주 간의 즉각적인 지분 정렬이 제한적임을 시사할 수 있으나, 고용 시작 후 인센티브 부여가 있을 수 있습니다.

이번 제출은 주로 절차적인 성격이며, 중요한 재무 정보나 iRhythm의 전략적 변화 신호를 포함하지 않습니다.

Présentation du formulaire 3/A : iRhythm Technologies, Inc. (IRTC) a déposé un formulaire 3 modifié pour le nouveau Directeur Technique (CTO) Brian Lee Lawrence. L’amendement, daté du 27/06/2025, corrige la déclaration initiale du 21/04/2025 en joignant la procuration qui avait été omise précédemment.

Points clés pour les investisseurs :

  • Aucune valeur détenue : Le rapport indique que M. Lawrence ne détient actuellement aucune action ni valeur dérivée d’IRTC.
  • Nature administrative : Aucun changement dans la structure du capital, les opérations ou les perspectives financières n’est divulgué ; le seul but est de fournir le document manquant.
  • Alignement des initiés : L’absence de détention peut indiquer un alignement en actions limité à court terme entre le CTO et les actionnaires, bien que des attributions d’incitations puissent suivre après le début de l’emploi.

Ce dépôt est essentiellement de nature procédurale et ne contient aucune information financière importante ni ne signale un changement stratégique pour iRhythm.

Überblick über Formular 3/A: iRhythm Technologies, Inc. (IRTC) reichte ein geändertes Formular 3 für den neu ernannten Chief Technology Officer Brian Lee Lawrence ein. Die Änderung vom 27.06.2025 korrigiert die ursprüngliche Einreichung vom 21.04.2025, indem die zuvor fehlende Vollmacht beigefügt wurde.

Wichtige Punkte für Investoren:

  • Keine Wertpapiere im Besitz: Der Bericht gibt an, dass Herr Lawrence derzeit keine Aktien oder derivative Wertpapiere von IRTC hält.
  • Administrativer Charakter: Es werden keine Änderungen an der Kapitalstruktur, den Geschäftsabläufen oder der finanziellen Prognose offengelegt; der einzige Zweck ist die Bereitstellung des fehlenden Dokuments.
  • Insider-Ausrichtung: Das Fehlen von Eigentum könnte auf eine begrenzte unmittelbare Eigenkapitalausrichtung zwischen dem CTO und den Aktionären hinweisen, obwohl Anreizzuteilungen nach Beginn der Anstellung erfolgen können.

Diese Einreichung ist überwiegend prozedural und enthält keine wesentlichen finanziellen Informationen oder signalisiert eine strategische Veränderung bei iRhythm.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Lawrence Brian Lee

(Last) (First) (Middle)
C/O IRHYTHM TECHNOLOGIES, INC.
699 8TH ST #600

(Street)
SAN FRANCISCO CA 94103

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/15/2025
3. Issuer Name and Ticker or Trading Symbol
iRhythm Technologies, Inc. [ IRTC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
04/21/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 Power of Attorney; This amendment is being filed to attach the Power of Attorney that was not included in the original Form 3 filed on April 21, 2025.
No securities are beneficially owned.
/s/ Marc Rosenbaum, attorney-in-fact 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did iRhythm Technologies (IRTC) file a Form 3/A on 06/27/2025?

The amendment attaches the Power of Attorney that was omitted from the original Form 3 filed on 04/21/2025.

Does the new CTO, Brian Lee Lawrence, own any IRTC shares?

No. The filing explicitly states that no securities are beneficially owned by Mr. Lawrence.

Is there any impact on iRhythm’s share count or dilution from this filing?

No. The Form 3/A is purely administrative and discloses zero securities owned, causing no dilution.

Will future insider transactions by the CTO appear in SEC filings?

Yes. Any subsequent grants, purchases or sales will be reported on Form 4 within two business days of the transaction.

Does the amendment signal any strategic change at iRhythm Technologies?

No. The document contains no operational or financial updates; it only corrects a prior filing omission.
Irhythm Technologies Inc

NASDAQ:IRTC

IRTC Rankings

IRTC Latest News

IRTC Latest SEC Filings

IRTC Stock Data

5.67B
31.78M
0.94%
112.45%
8.64%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
San Francisco